MicroRNAs (miRNAs) exert certain functions in the development of several cancers and can be a potential hallmark for cancer diagnosis and prognosis. MiR-191-5p has been proven to have high expression in breast cancer (BC), while its biological role and potential regulatory mechanisms in BC remain an open issue.
OBJECTIVE:
Bioinformatics was utilized to assay miR-191-5p level in BC tissues and predict its downstream target gene as well as the enriched signaling pathways of the target gene.
METHODS:
qRT-PCR was carried out to assay miR-191-5p and KLF6 levels in BC cells as well as miR-191-5p level in blood-derived exosomes from BC patients. Western blot was to examine the expression of proteins linked with cell adhesion, epithelial-mesenchymal transition (EMT), and exosome markers. A dual luciferase reporter assay was utilized to verify the interaction between miR-191-5p and KLF6. Abilities of cell phenotypes of BC cells were detected by CCK8, Transwell, and cell adhesion assay, separately.
RESULTS:
Upregulated miR-191-5p expression and downregulated KLF6 expression were observed in BC cells. There was a targeting relationship between miR-191-5p and KLF6. MiR-191-5p negatively regulated KLF6 to promote EMT and malignant progression of BC cells. Additionally, we described a dramatically high level of miR-191-5p in the blood exosomes of BC patients.
CONCLUSION:
MiR-191-5p advances the EMT of BC by targeting KLF6, indicating that miR-191-5p and KLF6 may be new biomarkers for BC.
Fahad UllahM. Breast cancer: Current perspectives on the disease status. Adv Exp Med Biol.2019; 1152: 51-64.
2.
SiegelRLMillerKDWagleNSJemalA. Cancer statistics, 2023. CA Cancer J Clin.2023; 73(1): 17-48.
3.
TrayesKPCokenakesSEH. Breast cancer treatment. Am Fam Physician.2021; 104(2): 171-178.
4.
GeayJF. Physiopathology, diagnosis and treatment of breast cancer. Soins.2013; (776): 25-9.
5.
QiYYanXWangCCaoHLiuG. Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: A systematic review and meta-analysis. Frontiers in Pharmacology.2022; 13: 1004821.
6.
HaqueWVermaVSchwartzMRLimBMangalampalliNButlerEBTehBS. Neoadjuvant chemotherapy for metaplastic breast cancer: Response rates, management, and outcomes. Clinical Breast Cancer.2022; 22(5): e691-e699.
7.
RenLChenHSongJChenXLinCZhangXHouNPanJZhouZWangLHuangDYangJLiangYLiJHuangHJiangL. MiR-454-3p-Mediated Wnt/beta-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis. Theranostics.2019; 9(2): 449-465.
8.
AnandarajahAChenYColditzGAHardiAStollCJiangS. Studies of parenchymal texture added to mammographic breast density and risk of breast cancer: A systematic review of the methods used in the literature. Breast Cancer Research: BCR.2022; 24(1): 101.
9.
ChenWZhengRBaadePDZhangSZengHBrayFJemalAYuXQHeJ. Cancer statistics in China, 2015. CA Cancer J Clin.2016; 66(2): 115-32.
10.
JiaoYLvQ. Does primary tumor resection induce accelerated metastasis in breast cancer? A review. The Journal of Surgical Research.2023; 283: 1005-1017.
11.
WeigeltBPeterseJLvan ’t VeerLJ. Breast cancer metastasis: Markers and models. Nat Rev Cancer.2005; 5(8): 591-602.
12.
ParkMKimDKoSKimAMoKYoonH. Breast cancer metastasis: Mechanisms and therapeutic implications. International Journal of Molecular Sciences.2022; 23(12).
13.
TanZSunWLiYJiaoXZhuMZhangJQingCJiaY. Current Progress of EMT: A new direction of targeted therapy for colorectal cancer with invasion and metastasis. Biomolecules.2022; 12(12).
14.
RenZYangTZhangPLiuKLiuWWangP. SKA2 mediates invasion and metastasis in human breast cancer via EMT. Mol Med Rep.2019; 19(1): 515-523.
15.
RiazSKKeYWangFKayaniMAMalikMF. A. Influence of SHH/GLI1 axis on EMT mediated migration and invasion of breast cancer cells. Sci Rep.2019; 9(1): 6620.
16.
HashemiMAraniHZOroueiSFallahSGhorbaniAKhaledabadiMKakavandATavakolpournegariASaebfarHHeidariHSalimimoghadamSEntezariMTaheriazamAHushmandiK. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomed Pharmacother.2022; 155: 113774.
17.
Di LevaGGarofaloMCroceCM. MicroRNAs in cancer. Annu Rev Pathol.2014; 9: 287-314.
18.
DarvishLBahreyni ToossiMTAzimianHShakeriMDolatEAhmadizad FirouzjaeiARezaieSAmraeeAAghaee-BakhtiariSH. The role of microRNA-induced apoptosis in diverse radioresistant cancers. Cellular Signalling.2023; 104: 110580.
19.
LuoBZhouKLiufuYHuangXZengHZhangZ. Novel insight into miRNA biology and its role in the pathogenesis of systemic lupus erythematosus. Frontiers in Immunology.2022; 13: 1059887.
20.
WangHTanZHuHLiuHWuTZhengCWangXLuoZWangJLiuSLuZTuJ. microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer.2019; 19(1): 738.
21.
ShiYWangJTaoSZhangSMaoLShiXWangWChengCShiYYangQ. miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway. Cellular Signalling.2023; 103: 110566.
22.
HouLLiuQZhaoYYangHMengQYuF. MicroRNA-140-5p inhibits cellular proliferation, migration and invasion by downregulating AKT/STAT3/NF-κB pathway in breast carcinoma cells. Acta Pharmaceutica (Zagreb, Croatia).2022; 72(4): 587-597.
23.
ZhouLYZhangFWTongJLiuF. MiR-191-5p inhibits lung adenocarcinoma by repressing SATB1 to inhibit Wnt pathway. Mol Genet Genomic Med.2020; 8(1): e1043.
24.
ChenPPanXZhaoLJinLLinCQuanJHeTZhouLWuXWangYNiLYangSLaiY. MicroRNA-191-5p exerts a tumor suppressive role in renal cell carcinoma. Exp Ther Med.2018; 15(2): 1686-1693.
25.
ChenBZhengZYYangJZLiXG. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway. Eur Rev Med Pharmacol Sci.2019; 23(9): 3611-3620.
26.
JingXDuLShiSNiuAWuJWangYWangC. Hypoxia-Induced Upregulation of lncRNA ELFN1-AS1 Promotes Colon Cancer Growth and Metastasis Through Targeting TRIM14 via Sponging miR-191-5p. Frontiers in Pharmacology.2022; 13: 806682.
27.
YangBWangYWQianLHXuYChenXChenYDLiuCTianYRZhangK. Downregulated miR-367-3p, miR-548aq-5p, and miR-4710 in Human Whole Blood: Potential biomarkers for breast cancer with axillary lymph node metastasis. Clinical Breast Cancer.2023; 23(2): 189-198.
28.
WangSLiLYangMWangXZhangHWuNJiaKWangJLiMWeiLLiuJ. Identification of Three Circulating MicroRNAs in Plasma as Clinical Biomarkers for Breast Cancer Detection. Journal of Clinical Medicine.2022; 12(1).
29.
TamkovichSTutanovOEfimenkoAGrigor’evaARyabchikovaEKirushinaNVlassovVTkachukVLaktionovP. Blood circulating exosomes contain distinguishable fractions of free and cell-surface-associated vesicles. Curr Mol Med.2019; 19(4): 273-285.
30.
HuangXWangLLiuWLiF. MicroRNA-497-5p inhibits proliferation and invasion of non-small cell lung cancer by regulating FGF2. Oncol Lett.2019; 17(3): 3425-3431.
31.
WanJWuW. Hyperthermia induced HIF-1a expression of lung cancer through AKT and ERK signaling pathways. J Exp Clin Cancer Res.2016; 35(1): 119.
32.
WangGZhaoWWangHQiuGJiangZWeiGLiX. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2. Med Sci Monit.2019; 25: 7209-7217.
33.
FuQZhangQLouYYangJNieGChenQChenYZhangJWangJWeiTQinHDangXBaiXLiangT. Primary tumor-derived exosomes facilitate metastasis by regulating adhesion of circulating tumor cells via SMAD3 in liver cancer. Oncogene.2018; 37(47): 6105-6118.
34.
LuJWRouziguATengLHLiuWL. The Construction and Comprehensive Analysis of Inflammation-Related ceRNA Networks and Tissue-Infiltrating Immune Cells in Ulcerative Progression. Biomed Res Int.2021; 2021: 6633442.
35.
LiHGaoYRenC. Focal adhesion kinase inhibitor BI 853520 inhibits cell proliferation, migration and EMT process through PI3K/AKT/mTOR signaling pathway in ovarian cancer. Discov Oncol.2021; 12(1): 29.
36.
AndugulapatiSBGourishettiKTirunavalliSKShaikhTBSistlaR. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-beta mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems. Phytomedicine.2020; 78: 153298.
37.
XuSTaoHCaoWCaoLLinYZhaoSMXuWCaoJZhaoJY. Ketogenic diets inhibit mitochondrial biogenesis and induce cardiac fibrosis. Signal Transduction and Targeted Therapy.2021; 6(1): 54.
38.
DuBShimJS. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules.2016; 21(7).
39.
PastushenkoIBlanpainC. EMT transition states during tumor progression and metastasis. Trends Cell Biol.2019; 29(3): 212-226.
40.
SaltonFVolpeMCConfalonieriM. Epithelial(-)Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis. Medicina (Kaunas).2019; 55(4).
41.
PetriBJKlingeCM. Regulation of breast cancer metastasis signaling by miRNAs. Cancer Metastasis Rev.2020; 39(3): 837-886.
42.
ChengHWangSFengR. STIM1 plays an important role in TGF-beta-induced suppression of breast cancer cell proliferation. Oncotarget.2016; 7(13): 16866-78.
43.
TanJJLongSZZhangT. Effects of LncRNA UNC5B-AS1 on adhesion, invasion and migration of lung cancer cells and its mechanism. Zhongguo Ying Yong Sheng Li Xue Za Zhi.2020; 36(6): 622-627.
DhawanAFriedrichsJBoninMVBejestaniEPWernerCWobusMChavakisTBornhauserM. Breast cancer cells compete with hematopoietic stem and progenitor cells for intercellular adhesion molecule 1-mediated binding to the bone marrow microenvironment. Carcinogenesis.2016; 37(8): 759-767.
46.
GaoXXieZWangZChengKLiangKSongZ. Overexpression of miR-191 predicts poor prognosis and promotes proliferation and invasion in esophageal squamous cell carcinoma. Yonsei Med J.2017; 58(6): 1101-1110.
47.
PengWZMaRWangFYuJLiuZB. Role of miR-191/425 cluster in tumorigenesis and diagnosis of gastric cancer. Int J Mol Sci.2014; 15(3): 4031-48.
48.
ChenXWangYWZhuWJLiYLiuLYinGGaoP. A 4-microRNA signature predicts lymph node metastasis and prognosis in breast cancer. Hum Pathol.2018; 76: 122-132.
49.
ChenCYangQWangDLuoFLiuXXueJYangPXuHLuJZhangALiuQ. MicroRNA-191, regulated by HIF-2alpha, is involved in EMT and acquisition of a stem cell-like phenotype in arsenite-transformed human liver epithelial cells. Toxicol In Vitro.2018; 48: 128-136.
50.
SharmaSNagpalNGhoshPCKulshreshthaR. P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer. RNA.2017; 23(8): 1237-1246.
51.
ShiSLiDLiYFengZDuYNieY. LncRNA CR749391 acts as a tumor suppressor to upregulate KLF6 expression via interacting with miR-181a in gastric cancer. Exp Ther Med.2020; 19(1): 569-578.
52.
NagpalNAhmadHMChameettachalSSundarDGhoshSKulshreshthaR. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFbeta-signaling in hypoxic microenvironment. Sci Rep.2015; 5: 9650.
53.
HeADXieWSongWMaYYLiuGLiangMLDaXWYaoGQZhangBXGaoCJXiangJZMingZY. Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6. Sci Rep.2017; 7(1): 3989.
HanXTJiangJQLiMZCongQM. Circular RNA circ-ABCB10 promotes the proliferation and invasion of thyroid cancer by targeting KLF6. Eur Rev Med Pharmacol Sci.2020; 24(3): 1271-1277.
56.
LiYHouCZDongYLZhuLXuH. Long noncoding RNA LINP1 promoted proliferation and invasion of ovarian cancer via inhibiting KLF6. Eur Rev Med Pharmacol Sci.2020; 24(1): 36-42.
57.
CieslaMSkrzypekKKozakowskaMLobodaAJozkowiczADulakJ. MicroRNAs as biomarkers of disease onset. Anal Bioanal Chem.2011; 401(7): 2051-61.
58.
JoyceDPKerinMJDwyerRM. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer. Int J Cancer.2016; 139(7): 1443-8.
